CHIL Achieves Record COVID-19 Test Production Capacity with Second Factory

In May 2021, CHIL rapidly commissioned its second manufacturing facility in just one month to meet the surging demand for COVID-19 diagnostics during the pandemic. Expanding from its first 1,000 m² factory, the additional 6,000 m² facility enabled the company to grow from one factory with 83 employees producing 150K tests per month to two factories employing 500 staff, achieving a daily production capacity exceeding 500K tests. This remarkable expansion established CHIL as a global high-capacity COVID-19 antigen test manufacturer, demonstrating outstanding operational performance and responsiveness during critical times.